Back to top
more

Amedisys (AMED)

(Delayed Data from NSDQ)

$100.98 USD

100.98
592,706

+0.03 (0.03%)

Updated Aug 13, 2025 04:00 PM ET

After-Market: $100.98 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 14% (34 out of 245)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Amedisys, Foot Locker, Shoe Carnival, Tractor Supply and Caseys General Stores

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: Helmerich & Payne, Manulife Financial, HEICO, Amedisys and Titan Machinery

Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor

by Zacks Equity Research

Zacks.com featured expert Kevin Matras highlights: BJ's Restaurants, O'Reilly Automotive, Amedisys, HCA Healthcare and Toyota Motor

Sweta Killa headshot

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Sweta Killa

Sector ETF report for PSCH

Sanghamitra Saha headshot

5 Quality Stock Picks Based on DuPont Analysis

by Sanghamitra Saha

Bet on five top-ranked stocks with higher ROE derived from the DuPont way.

Zacks Equity Research

Buy These 5 Low Leverage Stocks to Stay Away From Debt Traps

by Zacks Equity Research

Since debt-ridden companies are more vulnerable at times of crisis, it is better to avoid those. Of course, entirely avoiding companies with debt loads is virtually impossible.

Zacks Equity Research

Here Are 5 Stocks With Amazing Interest Coverage Ratio

by Zacks Equity Research

Interest Coverage Ratio is used to determine how effectively a company can pay the interest charged on its debt.

Zacks Equity Research

Amedisys Sees Hammer Chart Pattern: Time to Buy?

by Zacks Equity Research

Amedisys has been struggling lately, but the selling pressure may be coming to an end soon.

Sreyoshi Mukherjee headshot

Has the Trade Debacle Ended for US MedTech Space? 3 Picks

by Sreyoshi Mukherjee

As the trade war fears slowly dissipate, let's take a look at three profitable U.S. MedTech picks.

Zacks Equity Research

Here's Why You Should Add Amedisys (AMED) to Your Portfolio

by Zacks Equity Research

Amedisys (AMED) is developing and acquiring new business lines that will complement its existing home care and hospice business.

Zacks Equity Research

Amedisys (AMED) Gains As Market Dips: What You Should Know

by Zacks Equity Research

In the latest trading session, Amedisys (AMED) closed at $114.79, marking a +0.88% move from the previous day.

Zacks Equity Research

Is Amedisys (AMED) Stock Outpacing Its Medical Peers This Year?

by Zacks Equity Research

Is (AMED) Outperforming Other Medical Stocks This Year?

Zacks Equity Research

The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

by Zacks Equity Research

The Zacks Analyst Blog Highlights: Computer Programs and Systems, BioTelemetry, HMS, Amedisys and Molina Healthcare

Swarup Gupta headshot

5 Great Healthcare Stocks to Buy for 2019

by Swarup Gupta

Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

Nalak Das headshot

5 Nasdaq Composite Stocks That Braved the Index's Bloodbath

by Nalak Das

Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.

Madhura Bhattacharyya headshot

Ring in 2019 With These 7 Solid Growth Stocks in Your Kitty

by Madhura Bhattacharyya

Let's take a look at seven growth stocks that are poised to offer impressive returns in 2019.

Zacks Equity Research

Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems

by Zacks Equity Research

Zacks.com featured highlights include: Amedisys, Marine Products, Foot Locker, Systemax and Comfort Systems

Sanghamitra Saha headshot

Ride on DuPont Analysis With 5 Top Stocks

by Sanghamitra Saha

Have more faith in DuPont analysis than simple ROE calculation? Bet on these five stocks.

Zacks Equity Research

Should First Trust Mid Cap Growth AlphaDEX Fund (FNY) Be on Your Investing Radar?

by Zacks Equity Research

Style Box ETF report for FNY

Sapna Bagaria headshot

4 Healthcare Stocks That Popped More Than 100% in 2018

by Sapna Bagaria

Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.

Sweta Jaiswal headshot

4 Medical Device Stocks That More Than Doubled in 2018

by Sweta Jaiswal

Here are four medical device stocks which have performed really well in 2018 and should be on investors' radar next year as well.

Zacks Equity Research

Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock

by Zacks Equity Research

Zacks.com featured highlights include: Spirit Airlines, Middlesex Water, Amedisys, BioTelemetry and Great Lakes Dredge & Dock

Zacks Equity Research

5 Stocks With Recent Price Strength to Enhance Your Return

by Zacks Equity Research

Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.

Sweta Killa headshot

Should You Invest in the Invesco S&P SmallCap Health Care ETF (PSCH)?

by Sweta Killa

Sector ETF report for PSCH

Sreyoshi Mukherjee headshot

5 Stocks That Popped More Than 100% in 2018 Defying All Odds

by Sreyoshi Mukherjee

Five solid picks that defied the problems confronting the U.S. economy.